[go: up one dir, main page]

MX2018011350A - Metodo para acelerar la involucion e impedir la infeccion de glandulas mamarias en el secado. - Google Patents

Metodo para acelerar la involucion e impedir la infeccion de glandulas mamarias en el secado.

Info

Publication number
MX2018011350A
MX2018011350A MX2018011350A MX2018011350A MX2018011350A MX 2018011350 A MX2018011350 A MX 2018011350A MX 2018011350 A MX2018011350 A MX 2018011350A MX 2018011350 A MX2018011350 A MX 2018011350A MX 2018011350 A MX2018011350 A MX 2018011350A
Authority
MX
Mexico
Prior art keywords
drying
teat
mammary gland
preventing infection
chitosan solution
Prior art date
Application number
MX2018011350A
Other languages
English (en)
Inventor
Lacasse Pierre
Lanctôt Samuel
Fustier Patrick
R Taherian Ali
Bisakowski Barbara
Begin André
Original Assignee
Her Majesty The Queen In Right Of Canada As Represented By The Mini Of Agriculture And Agri Food
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Her Majesty The Queen In Right Of Canada As Represented By The Mini Of Agriculture And Agri Food filed Critical Her Majesty The Queen In Right Of Canada As Represented By The Mini Of Agriculture And Agri Food
Publication of MX2018011350A publication Critical patent/MX2018011350A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un metodo para prevenir infeccion intramamaria y acelerar la involucion mediante administrar un modificador de la respuesta biologica, especificamente una solucion de quitosano, al pezon de un mamifero en lactacion durante el secado. Una solucion de quitosano neutralizada con una base debil tal como ß-glicerofosfato puede permanecer liquida a temperatura ambiente para ser inyectada dentro de un pezon, pero puede formar un hidrogel a la temperatura del cuerpo dentro del pezon. La solucion de quitosano neutralizada puede tambien ser opcionalmente coadministrada con un sellante de pezones.
MX2018011350A 2016-03-18 2017-03-16 Metodo para acelerar la involucion e impedir la infeccion de glandulas mamarias en el secado. MX2018011350A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310025P 2016-03-18 2016-03-18
PCT/CA2017/050339 WO2017156632A1 (en) 2016-03-18 2017-03-16 Chitosan hydrogels for accelerating involution and preventing infection of the mammary gland at drying-off

Publications (1)

Publication Number Publication Date
MX2018011350A true MX2018011350A (es) 2019-06-06

Family

ID=59850126

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011350A MX2018011350A (es) 2016-03-18 2017-03-16 Metodo para acelerar la involucion e impedir la infeccion de glandulas mamarias en el secado.

Country Status (11)

Country Link
US (1) US10828319B2 (es)
EP (1) EP3429601A4 (es)
CN (1) CN109310705A (es)
AU (1) AU2017233727A1 (es)
BR (1) BR112018068794A2 (es)
CA (1) CA3015846A1 (es)
CL (1) CL2018002562A1 (es)
CO (1) CO2018011133A2 (es)
MX (1) MX2018011350A (es)
RU (1) RU2018135961A (es)
WO (1) WO2017156632A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7123971B2 (ja) * 2017-04-20 2022-08-23 ゾエティス・サービシーズ・エルエルシー 乳腺炎を処置する際に使用する動物用組成物、及び関連方法
CA3158368A1 (en) 2019-11-28 2021-06-03 Boehringer Ingelheim Vetmedica Gmbh Use of sglt-2 inhibitors in the drying-off of non-human mammals
CN111840212B (zh) * 2020-06-18 2023-07-21 余祖功 一种非人类动物用乳头封闭剂及其制备方法
CN120168507B (zh) * 2025-05-21 2025-09-19 中国农业大学 一种“回奶型”无抗干奶组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
CA2467049C (en) 2001-11-15 2011-04-12 Abdellatif Chenite Composition and method to homogeneously modify or cross-link chitosan under neutral conditions
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
WO2015093937A1 (en) * 2013-12-19 2015-06-25 N.V. Nutricia Lactobacillus salivarius for the treatment of mastitis
CN108601723B (zh) 2015-11-03 2022-05-17 硕腾服务有限责任公司 溶胶-凝胶聚合物复合材料及其用途

Also Published As

Publication number Publication date
US20190060352A1 (en) 2019-02-28
EP3429601A4 (en) 2019-11-27
EP3429601A1 (en) 2019-01-23
AU2017233727A1 (en) 2018-09-13
CA3015846A1 (en) 2017-09-21
RU2018135961A (ru) 2020-04-20
BR112018068794A2 (pt) 2019-04-09
WO2017156632A1 (en) 2017-09-21
CL2018002562A1 (es) 2019-02-15
CN109310705A (zh) 2019-02-05
CO2018011133A2 (es) 2018-10-31
US10828319B2 (en) 2020-11-10

Similar Documents

Publication Publication Date Title
MX2021015409A (es) Dispositivo y metodo para realizar conexiones asepticas.
MX2019006987A (es) Sistema y metodo configurados para proveer soporte extracorporeo para fetos prematuros.
MX393644B (es) Cateter con compuerta o accesorio luer hembra con septo antimicrobiano.
AR109529A1 (es) Dispositivo de muestreo de fluido
PH12016501671B1 (en) Novel polysaccharide and uses thereof
PH12020500371A1 (en) Spirocycle compounds and methods of making and using same
PH12020550449A1 (en) Variant icos ligand immunomodulatory proteins and related compositions and methods
EP4144401A3 (en) Antimicrobial caps for medical connectors
TWD211210S (zh) 病患連接裝置
WO2018019967A3 (en) Apparatus for mixing bone cement
MX2018011350A (es) Metodo para acelerar la involucion e impedir la infeccion de glandulas mamarias en el secado.
NZ713946A (en) Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
MX2016011682A (es) Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.
JOP20200023A1 (ar) مركبات حلقية لولبية وطرق تصنيعها واستخدامها
WO2017087827A8 (en) Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria
WO2017218922A8 (en) Compositions and methods for the treatment of bacterial infections
MY197524A (en) System of multiple bags and method for the preparation of hemocomponents
MX355853B (es) Composicion oftalmica para el tratamiento de infeccion ocular.
MX2018005085A (es) Nanoparticulas terapeuticas que comprenden un agente terapeutico y metodos de fabricacion y uso de las mismas.
BR112017007978A2 (pt) aparelho de retenção de pós-molde e método
MX2018007819A (es) Formula infantil que comprende peptidos de leche humana.
MX2017009313A (es) Formulaciones intravenosas de baclofeno y metodos de tratamiento.
WO2017007037A3 (en) Iron-oxidizing bacteria with good resistance to arsenic, a method for preparing said bacteria, a medium for said bacteria and a method for preparing scorodite using said bacteria
MX368669B (es) Procedimiento para la preparación de 4-amino-1-((1s,4r,5s)-2-fluor o-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirimidin-2-o na.
MX2018004656A (es) Baclofeno intravenoso y metodos de tratamiento.